what "research grade" means in UK regulatory and quality terms
Frequency depends on your goals: Energy or immune support: weekly or biweekly
After 36 weeks of treatment, participants who were switched to a placebo regained nearly half of their lost weight within a year
The retained ability of both GTR1 and GTR2 to transport nitrate corroborates such a de novo functional specification
Commercial Insurance: Tightening Coverage Many Plans Dropping or Restricting Coverage (Jan 2026) Effective January 1, 2026, multiple insurers have dropped or restricted GLP-1 coverage for weight loss , limiting it to type 2 diabetes or plans with explicit weight management benefits: [11] Health New England: Dropped Wegovy, Zepbound, and Saxenda coverage for individual and small group members effective January 1, 2026 Fallon Health: Community Care plans no longer cover weight loss medications as of January 1, 2026 BCBS, UnitedHealthcare, Cigna: Many plans restricting GLP-1s to type 2 diabetes only, unless employers opt for weight management riders CVS Caremark: Removed Zepbound from standard formulary effective July 1, 2025
The FTC would have had more market evidence of competitive alternatives when it began its PBM investigation